Evidence map›Paper›PMID 42631178›Full record

ArticleInternational medical case reports journal2026

Vitrectomy with Low-Dose Subretinal t-PA for Hemorrhage Due to Traumatic Choroidal Rupture: A Case Series.

Agnieszka Joanna Nowosielska, Grzegorz Rotuski

Abstract readCase Reports
In one paragraph

Article in International medical case reports journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Agnieszka Joanna NowosielskaOphthalmology Department, Warsaw Eye Hospital, Warsaw, Poland.
Grzegorz RotuskiOphthalmology Department, Warsaw Eye Hospital, Warsaw, Poland.ORCID 0000-0002-4640-8787

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Choroidal rupture with subretinal hemorrhage comprising the fovea is thought to have poor prognosis regardless of surgical interventions. Being a relatively rare entity, managing patients, referring them in time and standardizing a therapeutic approach remains challenging. Many eyecare practitioners opt solely for conservative treatment, without recurring to any surgical treatment. Case Reports: Three young adult males with blunt ocular trauma complicated by choroidal rupture with subretinal hemorrhage presented to the vitreoretinal surgeon appointment. All of them underwent pars plana vitrectomy with subretinal rtPA administration. All patients were then monitored for recovery with conservative treatment and despite the present post traumatic choroidal rupture, they achieved major improvement in visual acuity along with OCT parameters compared to their initial presentation. Conclusion: Not all vitreoretinal surgeons perform subretinal rtPA injection, partly due to not being trained in this aspect, but also due to controversies around this approach. Intravitreal rtPA injection is an easier alternative, although less impactful. Sometimes, even performing a gas endotamponade in the vitreous cavity without specific fibrinolytic treatment can improve results upon blood dislocation away from the fovea. Knowledge on the possibility of surgical intervention in patients with subretinal hemorrhage is important to be popularized among ophthalmologists, so they can refer these cases to vitreoretinal surgeons promptly instead of sticking to conservative treatment only, which may be the inferior choice in cases with macular involvement when time plays a key role.

Indexed as

macular surgeryrecombinant tissue plasminogen activatorsubretinal hemorrhagesubretinal injectionvitreoretinal surgery

Identifiers

PMID42631178
PMCPMC13496125

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.